Xtalpi’s last private fundraising was a $380 million Series D round in October 2021 that valued the company at about $2 billion.

The relative strength/seasonal cycle screening approach has generated outperformance since 2020. Here are the top five long and short sale prospects.

A year and a half ago, we were promised a recession. It didn’t arrive, but now chances are far higher of one arriving in due course

Some of things that helped boost the economy this year may hurt it next year,new research shows.

Taking a closer look at one of the largest companies in the pharmaceutical industry

Charlie Munger was a sage that left us with a bevy of wisdom about investing, business, and living a good life. In this article I focus on five profound lessons.